These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 34568267)
41. Disease Characteristics and Psychiatric Comorbidities in Adolescents with Anorexia Nervosa Hospitalized During COVID-19 Pandemic. Girardi M; Assalone C; Maines E; Genovese A; Naselli A; Nai Fovino L; Soffiati M; Franceschi R Front Biosci (Schol Ed); 2022 Oct; 14(4):28. PubMed ID: 36575838 [TBL] [Abstract][Full Text] [Related]
42. A case-control autopsy series of liver pathology associated with novel coronavirus disease (COVID-19). Righi FA; Vander Heide RS; Graham RP; Aubry MC; Trejo-Lopez JA; Bois MC; Roden AC; Reichard R; Maleszewski JJ; Alexander MP; Quinton RA; Jenkins SM; Hartley CP; Hagen CE Ann Diagn Pathol; 2024 Feb; 68():152240. PubMed ID: 37995413 [TBL] [Abstract][Full Text] [Related]
43. Host traits, ownership behaviour and risk factors of SARS-CoV-2 infection in domestic pets in Mexico. Espinosa-Gómez FC; Bautista E; Palacios-Cruz OE; Téllez-Ramírez A; Vázquez-Briones DB; Flores de Los Ángeles C; Abella-Medrano CA; Escobedo-Straffón JL; Aguirre-Alarcón H; Pérez-Silva NB; Solís-Hernández M; Navarro-López R; Aguirre AA Zoonoses Public Health; 2023 Jun; 70(4):327-340. PubMed ID: 36757053 [TBL] [Abstract][Full Text] [Related]
44. Delirium symptoms duration and mortality in SARS-COV2 elderly: results of a multicenter retrospective cohort study. Morandi A; Rebora P; Isaia G; Grossi E; Faraci B; Gentile S; Bo M; Valsecchi MG; Deiana V; Ghezzi N; Miksza J; Blangiardo P; Bellelli G Aging Clin Exp Res; 2021 Aug; 33(8):2327-2333. PubMed ID: 34176083 [TBL] [Abstract][Full Text] [Related]
45. Effects of SARS-CoV‑2 infections on inpatient mortality of geriatric patients after proximal femoral fracture surgery. Zajonz D; Vaitl P; Edel M; Fuchs O; Kübler F; Schneider P; Roth A; Prietzel T Orthopadie (Heidelb); 2022 Jul; 51(7):573-579. PubMed ID: 35776154 [TBL] [Abstract][Full Text] [Related]
46. Incidence, Risk, and Severity of SARS-CoV-2 Reinfections in Children and Adolescents Between March 2020 and July 2022 in Serbia. Medic S; Anastassopoulou C; Lozanov-Crvenkovic Z; Dragnic N; Petrovic V; Ristic M; Pustahija T; Tsakris A; Ioannidis JPA JAMA Netw Open; 2023 Feb; 6(2):e2255779. PubMed ID: 36780157 [TBL] [Abstract][Full Text] [Related]
47. Characteristics, outcome, duration of hospitalization, and cycle threshold of patients with COVID-19 referred to four hospitals in Babol City: a multicenter retrospective observational study on the fourth, fifth, and sixth waves. Sadeghi F; Halaji M; Shirafkan H; Pournajaf A; Ghorbani H; Babazadeh S; Ezami N; Fallhpour K; Fakhraie F; Gorjinejad S; Amoli SS; Amiri FH; Baghershiroodi M; Ahmadnia Z; Salehi M; Tourani M; Jafarzadeh J; Tabari FS; Ahmadian SR; Mohammadi Abandansari R; Jafarian F; Rouhi S; Zabihollahi A; Mostafanezhad S; Saeedi F; Ebrahimian A; Deldar Z; Zavareh MSH; Bayani M; Broun MB; Shirzad M; Sabbaghi S; Mohammadi M; Rahmani R; Yahyapour Y BMC Infect Dis; 2024 Jan; 24(1):55. PubMed ID: 38184533 [TBL] [Abstract][Full Text] [Related]
48. Excess Out-of-Hospital Mortality and Declining Oxygen Saturation: The Sentinel Role of Emergency Medical Services Data in the COVID-19 Crisis in Tijuana, Mexico. Friedman J; Calderón-Villarreal A; Bojorquez I; Vera Hernández C; Schriger DL; Tovar Hirashima E Ann Emerg Med; 2020 Oct; 76(4):413-426. PubMed ID: 33012377 [TBL] [Abstract][Full Text] [Related]
49. Comprehensive Evaluation of the Impact of Sociodemographic Inequalities on Adverse Outcomes and Excess Mortality During the Coronavirus Disease 2019 (COVID-19) Pandemic in Mexico City. Antonio-Villa NE; Fernandez-Chirino L; Pisanty-Alatorre J; Mancilla-Galindo J; Kammar-García A; Vargas-Vázquez A; González-Díaz A; Fermín-Martínez CA; Márquez-Salinas A; Guerra EC; Bahena-López JP; Villanueva-Reza M; Márquez-Sánchez J; Jaramillo-Molina ME; Gutiérrez-Robledo LM; Bello-Chavolla OY Clin Infect Dis; 2022 Mar; 74(5):785-792. PubMed ID: 34159351 [TBL] [Abstract][Full Text] [Related]
50. Age-dependent seroprevalence of SARS-CoV-2 antibodies in school-aged children from areas with low and high community transmission. Boey L; Roelants M; Merckx J; Hens N; Desombere I; Duysburgh E; Vandermeulen C Eur J Pediatr; 2022 Feb; 181(2):571-578. PubMed ID: 34455523 [TBL] [Abstract][Full Text] [Related]
51. SARS-CoV-2/COVID-19: Clinical Course Among Subjects HIV-1-Infected in Sao Paulo. Monteiro MA; Prates GS; de Lima Nascimento NA; Veiga APR; Magri MMC; Polis TJB; Gascon MRP; Ferreira MD; Tiberto L; Pereira LO; Alves W; Fonseca LAM; Duarte AJS; Casseb J Curr HIV Res; 2022; 20(6):457-462. PubMed ID: 35748552 [TBL] [Abstract][Full Text] [Related]
52. Low frequency of SARS-CoV2 infection in daycare centers during the reopening of school activities in the Southeast's poor area of Brazil. Soares GDS; Morais LV; Silva KCN; Ferreira EM; Shio MT; Romano CM; Conde CR; Sabino EC; França CN; Nali LH Rev Inst Med Trop Sao Paulo; 2022; 64():e46. PubMed ID: 35749418 [TBL] [Abstract][Full Text] [Related]
53. SARS-CoV-2 pandemic as a model to assess the relationship between intercurrent viral infections and disease activity in Multiple Sclerosis: A propensity score matched case-control study. Vercellino M; Bosa C; Alteno A; Muccio F; Marasciulo S; Garelli P; Cavalla P Mult Scler Relat Disord; 2023 Jun; 74():104715. PubMed ID: 37058763 [TBL] [Abstract][Full Text] [Related]
54. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial. Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924 [TBL] [Abstract][Full Text] [Related]
56. Epidemiology of SARS-CoV2 in Qatar's primary care population aged 10 years and above. Syed MA; Al Nuaimi AS; A/Qotba HA; Nasrallah GK; Althani AA; Yassine HM; Zainel AA; Khudadad H; Marji T; Veettil ST; Al-Jighefee HT; Younes S; Shurrab F; Al-Sadeq DW; AlFehaidi AAS; Yfakhroo AI; AlMesaifri MA; Al Mujalli H; Al Abdulla SA; Al Kuwari MG; Azad FM; Al Malki BAM; Abdulmalik MA BMC Infect Dis; 2021 Jul; 21(1):645. PubMed ID: 34225657 [TBL] [Abstract][Full Text] [Related]
57. Comorbidity, poverty and social vulnerability as risk factors for mortality in pregnant women with confirmed SARS-CoV-2 infection: analysis of 13 062 positive pregnancies including 176 maternal deaths in Mexico. Torres-Torres J; Martinez-Portilla RJ; Espino-Y-Sosa S; Estrada-Gutierrez G; Solis-Paredes JM; Villafan-Bernal JR; Medina-Jimenez V; Rodriguez-Morales AJ; Rojas-Zepeda L; Poon LC Ultrasound Obstet Gynecol; 2022 Jan; 59(1):76-82. PubMed ID: 34672382 [TBL] [Abstract][Full Text] [Related]
58. Assessing COVID-19 pandemic policies and behaviours and their economic and educational trade-offs across US states from Jan 1, 2020, to July 31, 2022: an observational analysis. Bollyky TJ; Castro E; Aravkin AY; Bhangdia K; Dalos J; Hulland EN; Kiernan S; Lastuka A; McHugh TA; Ostroff SM; Zheng P; Chaudhry HT; Ruggiero E; Turilli I; Adolph C; Amlag JO; Bang-Jensen B; Barber RM; Carter A; Chang C; Cogen RM; Collins JK; Dai X; Dangel WJ; Dapper C; Deen A; Eastus A; Erickson M; Fedosseeva T; Flaxman AD; Fullman N; Giles JR; Guo G; Hay SI; He J; Helak M; Huntley BM; Iannucci VC; Kinzel KE; LeGrand KE; Magistro B; Mokdad AH; Nassereldine H; Ozten Y; Pasovic M; Pigott DM; Reiner RC; Reinke G; Schumacher AE; Serieux E; Spurlock EE; Troeger CE; Vo AT; Vos T; Walcott R; Yazdani S; Murray CJL; Dieleman JL Lancet; 2023 Apr; 401(10385):1341-1360. PubMed ID: 36966780 [TBL] [Abstract][Full Text] [Related]
59. SARS-CoV-2 in Mexico: An Association Among Geography, Comorbidities, and Vitamin D Deficiency. Salas A; Rodríguez MA; Hernandes M; Muñoz VM; Cano A; Marmolejo LG; Calixto M; Imbert JL Am J Health Behav; 2023 Apr; 47(2):269-279. PubMed ID: 37226342 [No Abstract] [Full Text] [Related]
60. Probability of hospitalisation and death among COVID-19 patients with comorbidity during outbreaks occurring in Mexico City. Sifuentes-Osornio J; Angulo-Guerrero O; De Anda-Jáuregui G; Díaz-De-León-Santiago JL; Hernández-Lemus E; Benítez-Pérez H; Herrera LA; López-Arellano O; Revuelta-Herrera A; Rosales-Tapia AR; Suárez-Lastra M; Kershenobich D; Ruiz-Gutiérrez R J Glob Health; 2022 Nov; 12():05038. PubMed ID: 36342697 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]